Cargando…

Combining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1α pathway to predict survival in resectable pancreatic cancer

BACKGROUND: The dismal prognosis of patients diagnosed with pancreatic cancer points to our limited arsenal of effective anticancer therapies. Oncogenic K-RAS hyperactivation is virtually universal in pancreatic cancer, that confers drug resistance, drives aggressive tumorigenesis and rapid metastas...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, R, Smyrk, T C, Reed, N R, Schmidt, R L, Schnelldorfer, T, Chari, S T, Petersen, G M, Tang, A H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453663/
https://www.ncbi.nlm.nih.gov/pubmed/25584484
http://dx.doi.org/10.1038/bjc.2014.659